Leaflet: information for the user
PRINIVIL 5 mg tablets
Lisinopril
Read this leaflet carefully before you start taking this medicine,because it contains important information for you.
- Keep this leaflet, as you may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you and should not be given to others, even if they have the same symptoms, as it may harm them.
- If you experience any side effects, consult your doctor or pharmacist even if they are not listed in this leaflet. See section 4.
1.What Prinivil is and what it is used for
2. What you need to know before you start taking Prinivil
3.How to take Prinivil
4.Possible side effects
5.Storage of Prinivil
6. Contents of the pack and additional information
Prinivil belongs to a group of medications called angiotensin-converting enzyme inhibitors (ACE inhibitors).
Prinivil is indicated for:
Do not take Prinivil
Warnings and precautions
Consult your doctor or pharmacist before starting to use Prinivil.
Inform your doctor if you are in any of the following situations, as you may need to adjust your dose or discontinue treatment with Prinivil:
Your doctor may need to monitor your kidney function, blood pressure, and electrolyte levels in the blood (such as potassium) at regular intervals.
See also the information under the heading "Do not take Prinivil".
Inform your doctor or dentist that you are taking Prinivil before undergoing a surgical procedure with general or local anesthesia (even in the dentist's office), as a sudden drop in blood pressure may occur associated with the anesthesia.
You should inform your doctor if you think you may be pregnant (or could be). Prinivil is not recommended at the beginning of pregnancy and should not be used if you are more than 3 months pregnant, as it may cause severe damage to your baby if used from the third month of pregnancy.
Children and adolescents
Prinivil has been studied in children. For more information, talk to your doctor.
Use of Prinivil with other medications
Inform your doctor or pharmacist if you are using, or have used recently, other medications, or may need to use any other medication.
Be aware that these instructions may also apply to medications that have been used before or may be used later. The use of some medications with Prinivil may modify the effect (interaction) of both Prinivil and the medications, so in these cases, you may need to change your dose or discontinue treatment with one of them. Your doctor may need to adjust your dose and/or take other precautions.
Particularly, talk to your doctor or pharmacist if you are taking, have taken recently, or may need to take any of the following medications:
Prinivil with food and drinks
This medication can be taken before or after meals.
Pregnancy and breastfeeding
Consult your doctor or pharmacist before using any medication.
Pregnancy
You should inform your doctor if you think you may be pregnant (or could be). Normally, your doctor will advise you to stop taking Prinivil before becoming pregnant or as soon as you know you are pregnant and will advise you to take a different medication instead of Prinivil. Prinivil is not recommended at the beginning of pregnancy and should not be used if you are more than 3 months pregnant, as it may cause severe damage to your baby if used from the third month of pregnancy.
Breastfeeding
Inform your doctor if you are breastfeeding or are about to start breastfeeding.
Prinivil is not recommended for mothers who are breastfeeding, and if you want to breastfeed, your doctor may choose another treatment, especially if your baby is newborn or premature.
Driving and operating machines
It is unlikely that Prinivil tablets will affect your ability to drive vehicles or use machines; however, if you notice symptoms of dizziness or fatigue, avoid performing tasks that require special attention until you know how you tolerate the medication.
Follow exactly the administration instructions of this medication indicated by your doctor. Consult your doctor or pharmacist if you have doubts.
Remember to take your medication.
Your doctor will indicate how many tablets you should take each day and the duration of your treatment with Prinivil. Do not discontinue treatment before.
Adults
The usual recommended doses are:
Initial dose: 10 mg once a day.
Long-term dose: 20 mg once a day.
Initial dose: 2.5 mg once a day.
Long-term dose: 5 mg up to a maximum of 35 mg once a day.
Initial dose: 5 mg on the first and second day after the infarction, followed by 10 mg once a day.
The usual dose is 10 mg or 20 mg once a day.
Patients with kidney function impairment
Your doctor will adjust the dose.
Administration form:
Remember, the first dose of Prinivil may cause a greater decrease in blood pressure than what will be seen when continuing treatment. This effect may be felt as dizziness, in which case lying down will help.
If you estimate that the action of Prinivil is too strong or too weak, consult your doctor or pharmacist.
If you take more Prinivil than you should
If you take more Prinivil than you should, consult your doctor or pharmacist immediately.
The most common symptoms in case of overdose are: hypotension (low blood pressure), shock, renal insufficiency (kidney function impairment), hyperventilation (rapid breathing), tachycardia (increased heart rate), palpitations (rapid and irregular heartbeat), bradycardia (decreased heart rate), dizziness, anxiety, and cough.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20 indicating the medication and the amount ingested.
If you forget to take Prinivil
Do not take a double dose to compensate for the missed doses and wait for the next administration.
If you discontinue treatment with Prinivil
Your doctor will indicate the duration of your treatment with Prinivil. Do not discontinue treatment before, even if you feel better.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Medicine side effects are classified as follows:
Very common: (may affect more than 1 in 10 people)
Common: (may affect up to 1 in 10 people)
Uncommon: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1,000 people)
Very rare: (may affect up to 1 in 10,000 people)
Unknown frequency (cannot be estimated from available data)
Very common: (may affect more than 1 in 10 people)
Common: (may affect up to 1 in 10 people)
Uncommon: (may affect up to 1 in 100 people)
Rare: (may affect up to 1 in 1,000 people)
Very rare: (may affect up to 1 in 10,000 people)
Side effects observed in people treated with Prinivil, of unknown causal relationship:
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Unknown frequency (cannot be estimated from available data)
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep out of reach and sight of children.
No special storage conditions are required.
Do not use Prinivil after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of packaging and unused medicines at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medicines. By doing so, you will help protect the environment.
Composition of Prinivil
Appearance of the product and contents of the packaging
Prinivil 5 mg is presented in the form of white tablets. Each package contains 60 tablets.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
PAN QUÍMICA-FARMACÉUTICA, S.A.
Rufino González, 50
28037 Madrid
Spain
Responsible for manufacturing
ROVI Pharma Industrial Services, S.A.
Vía Complutense, 140
Alcalá de Henares 28805 – Madrid
(Spain)
Local representative:
Laboratorios Farmacéuticos ROVI, S.A.
Julián Camarillo, 35
28037 Madrid
Spain
Last review date of this prospectus: April 2020
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.